China Nuokang Bio-Pharmaceutical Inc.

SEC Filings

Home > Investor Relations > SEC Filings

Receive E-mail Alerts

SEC Filings Keyword Search (View search tips)

Groupings Filter (View SEC Groupings descriptions)

View Section 16 Filings (3,4,5)

<< First | Previous | Next | Last >>

Filing Date	Form	Description	Filing Group	Downloads
02/14/12	SC 13G	statement of beneficial ownership	SC 13G
02/06/12	SC 13G/A	amended statement of beneficial ownership	SC 13G/A
12/28/11	6-K	report of foreign issuer	6-K
12/22/11	6-K	report of foreign issuer	6-K
11/25/11	6-K	report of foreign issuer	6-K
11/18/11	6-K	report of foreign issuer	6-K
08/29/11	6-K	report of foreign issuer	6-K
06/03/11	20-F	annual report for foreign private issuers	20-F
05/26/11	6-K	report of foreign issuer	6-K
04/01/11	6-K	report of foreign issuer	6-K

<< First | Previous | Next | Last >>

= add PDF file to Briefcase

Stock Information

NKBP (Common Stock)
Exchange	NASDAQ (US Dollar)
Price	$2.96
Change (%)	0.11 (3.86%)
Volume	1,900
Data as of 02/22/12 1:14 PM ET Minimum 20 minutes delay Refresh quote

Investor Tools

Print Page

E-mail Page

Shareholder Briefcase

Download Library

RSS Feeds

E-mail Alerts

IR Contacts

Financial Tear Sheet

ICR, Inc.
In the U.S.:
Ashley De Simone
Phone: +1-646-277-1200
E-mail: Ashley.Desimone@icrinc.com

In China:
Wen Lei Zheng
Phone: +86-10-65837510
E-mail: WenLei.Zheng@icrinc.com

Nuokang's Consultant Team
Steven Duan
Phone: +86-24-24696037